[Toxicology of dilazep, a new coronary active agent].
D000014:Abnormalities, Drug-Induced; D000284:Administration, Oral; D000818:Animals; D001381:Azepines / Q000008:administration & dosage / Q000633:toxicity*; D001565:Benzoates / Q000008:administration & dosage / Q000633:toxicity; D003331:Coronary Vessels; D004285:Dogs; D005260:Female; D005298:Fertility / Q000187:drug effects; D005333:Fetus / Q000187:drug effects; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D011247:Pregnancy; D011817:Rabbits; D051381:Rats; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000633:toxicity*
D001381:Azepines; D001565:Benzoates; D014665:Vasodilator Agents
Zur Toxikologie von Dilazep, einer neuen koronaraktiven Substanz.